Now, Sponsors Can Build Their Own Recruitment Knowledge Base


By Deborah Borfitz

August 18, 2008 | Enrollment success might be a more common occurrence if study sponsors had a better means to tap their existing know-how about patient recruitment across clinical trials. A Web-based “Center of Excellence” product recently offered by e-recruitment company TCN e-Systems will do just that, says Jaime Cohen, data management lead.

“An amazing wealth of patient recruitment data exists within sponsor organizations, but it seldom resides in one place that everyone can easily access,” says Cohen. “The data and expertise necessary for patient recruitment is too mission-critical to reside in silos. All too often, only a handful of individuals possess the strategic knowledge or perspective to leverage this data to inform the enrollment process.”

 Jaime Cohen 
Jaime Cohen

The new tool is designed to “institutionalize” patient recruitment expertise in the same way that the company’s flagship TrialCENTRALNet product has been used on a protocol to protocol basis by BBK Worldwide, a patient recruitment company under common ownership with TCN e-Systems, for the past seven years. It was developed in response to a movement among industry sponsors to bring responsibility for enrollment success in-house, says Cohen. “Three to five years ago…a study would be extended [to accommodate recruitment delays]. There was nonchalance about it.”

TCN e-Systems’ Center of Excellence is a framework to build institutional knowledge, including “lessons learned” from previous studies that can be applied to current and future trials, says Cohen. Many sponsors try to accomplish this via a paper-based library of materials produced and approved by regulatory authorities for a specific trial. The new tool makes the hunt for relevant information less cumbersome by putting everything online and searchable in Google-like fashion.

In addition to BBK Worldwide, two large industry sponsors are already using the Center of Excellence product. Both of these companies are in the initial three-to-six-month process of building their electronic library, says Cohen, and suffering none of the usual “analysis paralysis” regarding what documents should be imported or how it should be categorized and accessed. Those answers are built into the product.

A companion online training product, QuickTrainer, is also available to help companies build their own patient recruitment infrastructure in-house, says Cohen. The eight-module, Web-based program includes reading assignments and practical exercises to help users understand recruitment essentials and how to apply them to current clinical projects. Exercises are reviewed by a patient recruitment advisor from BBK, which recently released a book (Reinventing Patient Recruitment: Revolutionary Ideas for Clinical Trial Success) upon which course content is partially drawn.

Center of Excellence has the same look and feel as TrialCENTRALNet, says Cohen, so the user interface is easy to navigate and screens are uncluttered. “It provides [users] with the information [they need] in just a few clicks.

Perhaps the most important feature of the new tool is integration of a “site readiness index,” says Cohen, which organizes and follows the process from site identification until the first patient is screened and “the clock starts ticking on patient recruitment.” Sponsors rarely meet site readiness goals and, up to now, have had a tough time even identifying bottlenecks telling them where to target their resources. The Center of Excellence product would be superfluous if it failed to address that issue, she notes.

________________________________

This story first appeared in eCliniqua,one of Bio-IT World’s free e-newsletters. Subscribe here.

 

 

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.